FDA Letter API

Accurate RX Pharmacy Consulting LLC

Letter data

Company
Accurate RX Pharmacy Consulting LLC
Recipient
Jeffrey Lyon | General Manager | Accurate RX Pharmacy Consulting LLC | Optum Infusion Services | 15529 College Blvd | Lenexa | , | KS | 66219 | United States
Issue date
2022-06-16
Posted date
Not available
FDA office
Division of Pharmaceutical Quality Operations III
Subject
Not available
Product
Drugs
CMS ID
604449
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Accurate RX Pharmacy Consulting LLC MARCS-CMS 604449 — June 16, 2022 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: UPS Next Day Product: Drugs Recipient: Recipient Name Jeffrey Lyon Recipient Title General Manager Accurate RX Pharmacy Consulting LLC Optum Infusion Services 15529 College Blvd Lenexa , KS 66219 United States Issuing Office: Division of Pharmaceutical Quality Operations III United States Dear Mr. Lyons: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (WL_604449) issued on September 2, 2020. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Nicholas F. Lyons Director of Compliance Division of Pharmaceutical Quality Operations III Content current as of: 06/22/2022 Regulated Product(s) Drugs